Jonathann Kuo, MD




BA: Boston University
MD: Boston University
Residency: New York Presbyterian Hospital / Weill Cornell
Fellowship: New York Presbyterian Hospital / Hospital for Special Surgery / Memorial Sloan Kettering Cancer Center

Founder, CEO, & Medical Director, Pain Medicine

Jonathann Kuo, MD is a double Board-Certified Pain Management Specialist and Anesthesiologist. He is the founder of Hudson Health, an innovative healthcare system with three integrated practices: Hudson Medical for interventional regenerative pain management, Hudson Mind for interventional mental health, and The Longevity Center by Hudson Health for regenerative and longevity medicine.
Since opening Hudson in 2010, Dr. Kuo and his group have treated over 30,000 patients. His dedication to patient care is matched by his steadfast contributions to clinical research. Having collaborated with renowned doctors and health organizations across the globe, Dr. Kuo has emerged as a prominent thought leader in regenerative therapies.
In his spare time, Dr. Kuo is an accomplished artist who has exhibited at several galleries and displays many of his works across Hudson Health’s TriBeCa and West Village practices. He also enjoys biohacking, cycling, travel gastronomy, and spending time with his growing family.
Dr. Kuo graduated from the prestigious 7 year accelerated BA/MD program at Boston University. He then completed his training at one of New York’s top institutions, New York Presbyterian Hospital. He received additional fellowship training in Pain Management at Memorial Sloan Kettering Hospital and the Hospital for Special Surgery.

Hudson Health’s robust Regenerative Medicine practice has administered over 2000 cases to date, using proprietary methods for extracting the highest concentrations of biologics. Hudson Medical is also the first practice in the US to publish safety data on the use of exosomes in spinal applications. As a regenerative medicine thought leader,  Dr. Kuo is committed to  spearheading new studies on the therapeutic potential of regenerative treatments.  

Having performed over 30,000 spinal and joint procedures over the course of his career, Dr. Kuo is a highly skilled and proven interventionist,  renowned for his precision and use of x-ray and ultrasound imaging. He has also integrated advanced regenerative medicine products into his treatment arsenal, including exosomes, concentrated platelet-rich plasma, and peptides. Through regenerative therapies, his procedures stimulate natural healing and regeneration of damaged tissue.

Dr. Kuo actively contributes to clinical research that evaluates the newest biologics and their applications across degenerative spinal and joint and systemic inflammatory conditions. He has traveled across the globe to collaborate with leading laboratories and thought leaders across the growing regenerative medicine landscape. 

Dr. Kuo has co-authored numerous publications on the use of NAD+, exosomes as potential Long COVID-19 treatments, and the efficacy of Dual Sympathetic Blocks in treating anxiety disorders. He is currently involved in three clinical research projects.

More about Dr. Kuo


English, Chinese (Mandarin), Chinese (Cantonese), Taiwanese

Hospital affiliation

North Shore / Long Island Jewish Hospital, Mt. Sinai / Beth Israel Medical Center
Rationale for NAD+ Metabalome Disruption as a Pathogenic Mechanism of Post-Acute COVID 19 Syndrome


Areas of Interest

Dr. Kuo’s research interests include Regenerative Medicine using Bone Marrow Concentrate which contains stem cells, and Platelet-rich plasma (PRP).
Dr. Kuo’s research interests include Regenerative Medicine using Bone Marrow Concentrate which contains stem cells, and Platelet-rich plasma (PRP).

Clinical Trials

fMRI evaluation of the effect of Stellate Ganglion Blocks for PTSD, in conjunction with NYU Langone and the Stella Center

Clinical Trial

Thought Leadership